How Tylenol became a medicinal scapegoat

Taking stock of the drug industry, from the lab to the medicine chest

September 25, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Charlie Knoblock/AP STAT+ | From an elixir for 'little hotheads' to deadly overdoses, how Tylenol became a medicinal scapegoat Tylenol's history spans kids' medicine, deadly overdoses, and corporate crises. Now Trump's autism claims put acetaminophen in a crossfire By Megan Molteni STAT+ | As the U.S. dials back mRNA research, the U.K. tries to seize an opportunity A ribbon-cutting ceremony in Harwell, England, shows how the U.K. has plans to be a hub of mRNA activity as the U.S. cuts back mRNA research under RFK Jr. By Andrew Joseph STAT reporters break down Trump's announcement on Tylenol, autism and vaccines President Trump's announcement on autism gained huge attention this week. STAT's Alex Hogan spoke with colleagues who provided key context and explanations. By Alex Hogan

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser